AHI Advanced Human Imaging Ltd ADRs
Avadim Health, Inc., a healthcare and wellness company, develops, manufactures, and markets topical products for the institutional care and consumer markets. It operates through Retail Pharmacy/Consumer and Institutional Care segments. The company develops products based on its proprietary technology platform Bionome Engineered Platform, to target areas of topical immune health, neuromuscular health, and skin barrier health. It markets a portfolio of products that address pain, infections, muscle cramps and spasms, symptoms of restless leg, and joint discomfort, as well as provides consulting services. The company sells its products to retail outlets, such as grocery stores and pharmacies; and acute-care hospitals and nursing homes, as well as other long-term care facilities, including short-term rehabilitation and other facilities designed for post-hospitalization care during recovery. It also sells products online. The company was formerly known as Avadim Technologies Inc and changed its name to Avadim Health, Inc. in September 2018. Avadim Health, Inc. was founded in 2007 and is based in Asheville, North Carolina. This is an ADR of a company whose stock trades outside of the U.S. as the symbol AT:AHI.
$0.36 -0.00 (-0.64%)
As of 03/24/2023 16:00:00 EST IEX book CBOE book
Security Information
Category1: US Equity
Category2: ADRs
Category3: Micro cap
GICS sector: Information Technology
Industry: Software—Application
Index country: Australia
Country of incorporation:
IPO date: 11/19/2021
Outstanding shares: 28,007,710
Average volume: 15,116
Market cap: $10,147,193
Current dividend yield: 0.00%
All SEC filings: SEC Edgar Online
Annual filings: 20-F
Sedol:
Valuation (See tab for details)
PE ratio: 0.00
PB ratio: 0.00
PS ratio: 0.00
Return on equity: 0.00%
Net income %: 0.00%